Assenagon Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
482,964
-190,325
| -28% | -$4.55M | 0.02% | 416 |
|
|
2025
Q1 | $16.7M | Buy |
673,289
+221,196
| +49% | +$5.5M | 0.03% | 337 |
|
|
2024
Q4 | $8.52M | Sell |
452,093
-101,021
| -18% | -$1.9M | 0.01% | 528 |
|
|
2024
Q3 | $8.32M | Buy |
553,114
+419,656
| +314% | +$6.32M | 0.02% | 557 |
|
|
2024
Q2 | $3.82M | Sell |
133,458
-62,837
| -32% | -$1.8M | 0.01% | 688 |
|
|
2024
Q1 | $5.74M | Sell |
196,295
-50,326
| -20% | -$1.47M | 0.01% | 553 |
|
|
2023
Q4 | $8.32M | Buy |
246,621
+160,149
| +185% | +$5.4M | 0.02% | 472 |
|
|
2023
Q3 | $2.65M | Sell |
86,472
-121,415
| -58% | -$3.73M | 0.01% | 732 |
|
|
2023
Q2 | $8.33M | Buy |
207,887
+56,063
| +37% | +$2.25M | 0.03% | 366 |
|
|
2023
Q1 | $6.2M | Buy |
+151,824
| New | +$6.2M | 0.02% | 497 |
|
|
2022
Q1 | – | Sell |
-140,468
| Closed | -$8.45M | – | 1473 |
|
|
2021
Q4 | $8.45M | Buy |
140,468
+108,873
| +345% | +$6.55M | 0.02% | 338 |
|
|
2021
Q3 | $1.77M | Sell |
31,595
-37,171
| -54% | -$2.08M | 0.01% | 704 |
|
|
2021
Q2 | $4.17M | Hold |
68,766
| – | – | 0.01% | 495 |
|
|
2021
Q1 | $4.82M | Sell |
68,766
-5
| -0% | -$350 | 0.02% | 489 |
|
|
2020
Q4 | $4.12M | Buy |
+68,771
| New | +$4.12M | 0.02% | 355 |
|
|
2020
Q3 | – | Sell |
-73,202
| Closed | -$3.84M | – | 1261 |
|
|
2020
Q2 | $3.84M | Buy |
+73,202
| New | +$3.84M | 0.02% | 374 |
|